Neuropace, Inc. NPCE Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s restricted cash?
- Neuropace, Inc. (NPCE) reported restricted cash of $852K in Q1 2026.
- How has Neuropace, Inc.'s restricted cash changed year-over-year?
- Neuropace, Inc.'s restricted cash increased by 598.4% year-over-year, from $122K to $852K.
- What is the long-term trend for Neuropace, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s restricted cash has grown at a -19.7% compound annual growth rate (CAGR), from $366K to $122K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.